Immature dendritic cells generated with low doses of GM‐CSF in the absence of IL‐4 are maturation resistant and prolong allograft survival in vivo

MB Lutz, RM Suri, M Niimi, ALJ Ogilvie… - European journal of …, 2000 - Wiley Online Library
MB Lutz, RM Suri, M Niimi, ALJ Ogilvie, NA Kukutsch, S Rößner, G Schuler, JM Austyn
European journal of immunology, 2000Wiley Online Library
Dendritic cells (DC) were cultured from mouse bone marrow (BM) progenitors in low
concentrations of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF)(GMlo DC)
by two different protocols. The phenotype and functional properties of these GMlo DC were
compared to those of standard BM‐DC cultures generated in high concentrations of GM‐
CSF (GMhi DC) or in low GM‐CSF plus IL‐4 (GMlo/IL‐4 DC). An effect of IL‐4 on maturation
was observed only at low but not high doses of GM‐CSF. Compared to mature DC, GMlo DC …
Abstract
Dendritic cells (DC) were cultured from mouse bone marrow (BM) progenitors in low concentrations of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) (GMlo DC) by two different protocols. The phenotype and functional properties of these GMlo DC were compared to those of standard BM‐DC cultures generated in high concentrations of GM‐CSF (GMhi DC) or in low GM‐CSF plus IL‐4 (GMlo/IL‐4 DC). An effect of IL‐4 on maturation was observed only at low but not high doses of GM‐CSF. Compared to mature DC, GMlo DC were phenotypically immature, weak stimulators of allogeneic and peptide‐specific T cell responses, but substantially more potent in presentation of native protein. Immature GMlo DC were resistant to maturation by lipopolysaccharide, TNF‐α or anti‐CD40 monoclonal antibodies, as the expression of co‐stimulatory molecules was not increased, and stimulatory activity in oxidative mitogenesis was not enhanced. These maturation‐resistant immature GMlo DC induced T cell unresponsiveness in vitro and in vivo. GMlo DC also prolonged haplotype‐specific cardiac allograft survival (from 8 days to >100 days median survival time) when they were administered 7 days (but not 3, 14 or 28 days) before transplantation. Our findings may have important implications for future studies in T cell tolerance induction in vivo.
Wiley Online Library